Gout flare prophylaxis during management of chronic gout with febuxostat, a non-purine selective inhibitor of xanthine oxidase.

被引：0
作者：
Wortmann, R
Becker, MA
Schumacher, HR
MacDonald, P
Palo, WA
Joseph-Ridge, N
机构：
[1] Univ Oklahoma, Tulsa, OK USA
[2] Univ Chicago, Chicago, IL 60637 USA
[3] Univ Penn, VAMC, Philadelphia, PA 19104 USA
[4] TAP Pharmaceut Prod Inc, Lake Forest, IL USA
来源：
ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S335 / S336
页数：2
相关论文
共 50 条
[21]   Effect of febuxostat, a novel non-purine, selective inhibitor of xanthine oxidase (NP-SIXO), on enzymes in purine and pyrimidine metabolism pathway. [J].
Lin, Z ;
Takano, Y ;
Horiuchi, H .
ARTHRITIS AND RHEUMATISM, 2003, 48 (09) :S531-S531
[22]   EFFECTS OF XANTHINE OXIDASE INHIBITOR ON CLINICAL MANIFESTATIONS + PURINE METABOLISM IN GOUT [J].
RUNDLES, RW ;
SILBERMAN, HR ;
ELION, GB ;
HITCHINGS, GH .
ANNALS OF INTERNAL MEDICINE, 1964, 60 (04) :717-+
[23]   PRECLINICAL IN VITRO AND IN VIVO EFFICACY STUDIES OF TIGULIXOSTAT, A SELECTIVE NON-PURINE XANTHINE OXIDASE INHIBITOR [J].
Kumar, A. ;
Kim, D. W. ;
Kim, S. .
ANNALS OF THE RHEUMATIC DISEASES, 2024, 83
[24]   Febuxostat (TMX-67), a novel, non-purine, selective inhibitor of xanthine oxidase, is safe and decreases serum urate in healthy volunteers [J].
Becker, MA ;
Kisicki, J ;
Khosravan, R ;
Wu, J ;
Mulford, D ;
Hunt, B ;
MacDonald, P ;
Joseph-Ridge, N .
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2004, 23 (8-9) :1111-1116
[25]   A phase 2, long term open-label safety and efficacy study of febuxostat, a novel non-purine, selective inhibitor of xanthine oxidase [J].
Schumacher, HE ;
Wortmann, R ;
Becke, MA ;
MacDonald, P ;
Palo, WA ;
Eustace, D ;
Streit, J ;
Joseph-Ridge, N .
ARTHRITIS AND RHEUMATISM, 2004, 50 (09) :S335-S335
[26]   Non-purine selective xanthine oxidase inhibitor ameliorates glomerular endothelial injury in InsAkita diabetic mice [J].
Itano, Seiji ;
Kadoya, Hiroyuki ;
Satoh, Minoru ;
Nakamura, Takashi ;
Murase, Takayo ;
Sasaki, Tamaki ;
Kanwar, Yashpal S. ;
Kashihara, Naoki .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2020, 319 (05) :F765-F772
[27]   Placebo-Controlled, Double-Blind Study of the Non-Purine-Selective Xanthine Oxidase Inhibitor Febuxostat (TMX-67) in Patients With Hyperuricemia Including Those With Gout in Japan [J].
Naoyuki, Kamatani ;
Shin, Fujimori ;
Toshikazu, Hada ;
Tatsuo, Hosoya ;
Kenjiro, Kohri ;
Toshitaka, Nakamura ;
Takanori, Ueda ;
Tetsuya, Yamamoto ;
Hisashi, Yamanaka ;
Yuji, Matsuzawa .
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2011, 17 (04) :S19-S26
[28]   3,5,2′,4′-Tetrahydroxychalcone, a new non-purine xanthine oxidase inhibitor [J].
Niu, Yanfen ;
Zhu, Huajie ;
Liu, Jia ;
Fan, Huafang ;
Sun, Ling ;
Lu, Wei ;
Liu, Xu ;
Li, Ling .
CHEMICO-BIOLOGICAL INTERACTIONS, 2011, 189 (03) :161-166
[29]   Placebo-Controlled Double-Blind Dose-Response Study of the Non-Purine-Selective Xanthine Oxidase Inhibitor Febuxostat (TMX-67) in Patients With Hyperuricemia (Including Gout Patients) in Japan [J].
Naoyuki, Kamatani ;
Shin, Fujimori ;
Toshikazu, Hada ;
Tatsuo, Hosoya ;
Kenjiro, Kohri ;
Toshitaka, Nakamura ;
Takanori, Ueda ;
Tetsuya, Yamamoto ;
Hisashi, Yamanaka. ;
Yuji, Matsuzawa .
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2011, 17 (04) :S35-S43
[30]   A novel electrochemical sensor based on gold nanoparticles decorated functionalized carbon nanofibers for selective determination of xanthine oxidase inhibitor febuxostat in plasma of patients with gout [J].
Ibrahim, Hossieny ;
Temerk, Yassien .
SENSORS AND ACTUATORS B-CHEMICAL, 2021, 347
12345